Search PubMed⌕ Search

Biomedical subjects

S Celis

Publications and source records attributed to S Celis.

4 recordsLinked to original sources
PubMed2007

Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients.

OBJECTIVE: Lower levels of long-chain omega-3 polyunsaturated fatty acids (n-3 LCPUFAs) and increased inflammation have been associated with both depressive disorder and myocardial infarction (MI). The present study investigated whether patients who develop depression post-MI, have higher arachidonic acid/eicosapentanoic acid (AA/EPA) ratios than non-depressed post-MI patients and whether depressed post-MI patients have signs of increased inflammation as measured by C-reactive protein (CRP). METHOD: Serum AA/EPA ratio and plasma CRP levels were quantified in 50 post-MI patients, of which 29 were depressed and 21 non-depressed. RESULTS: Compared with the non-depressed group, depressed post-MI patients had significantly higher AA/EPA ratios. No significant difference was observed in CRP levels. CONCLUSION: Depressed post-MI patients had lower levels of n-3 LCPUFAs as measured by mean AA/EPA ratio and no signs of increased inflammation as determined by CRP levels.

Adult↗
PubMed1994

[HIV and blood donors: past, present and future].

PURPOSE: To evaluate the changes in the spectrum of HIV-positive blood donors along seven years. PATIENTS AND METHODS: The municipal Blood Bank of Caracas Federal District examined 193,796 blood donors between 1986 and 1992. Anti-HIV antibodies were determined by the following methods: Ortho HIV-Elisa Test System (59.5% of the samples), Abbott Recombinant HIV-EIA (28.6%), Vironostika HIV Microelisa System-Organon Teknika (2.1%), Bio-Test anti-HIV Recombinant Elisa (2.1%), and Recombigen (env and gag) HIV Cambridge Biotech (7.7%). Results confirmation was performed with Biotech/Dupont HIV-I Western Blot Kit, Chiron Riba HIV 216 Test System and Inno-Lia HIV 1/2 Ab immunogenetics SA. RESULTS: Slow but progressive increase of positive results was seen in the blood donors along the years, from 0.05% in 1986 to 0.31% in 1992. Higher prevalence was seen in males (p < 0.001), although absolute increase in the number of positive females was found by 1992 (p < 0.05). According to their type, 80.6% of the donors were patient-related (RD), 13% attended mobile blood-drawing units (MU) and 6.4% were VD (p < 0.001), with a trend to increase amongst DR and decrease amongst MV. The majority of the positive donors pertained to homo-or bisexuals (60.5%), although they showed progressive decrease, whereas the positive findings increased in the promiscuous heterosexual group and amongst those having contacts with persons at risk. CONCLUSIONS: High prevalence of HIV-positive donors is found, the expected figure for 1995 being 0.37% if the present trends are maintained. Thus, a better selection of blood donors is recommended by means of careful enquiries, the use of optimal reagents capable of shortening the window period, deferring people at risk from blood donation, and promoting altruistic voluntary donation of blood.

Adolescent↗
PubMed1991

[Post-transfusional hepatitis. Preliminary study].

In Venezuela post-transfusional hepatitis (PTH) data is unknown. We studied, prospectively, 147 patients who received blood transfusions (1 to 48 different blood components). They were screened for HBsAg (Ortho HBsAg Elisa Test System), anti HBc (Ortho HBc Elisa Test System and CORZYME, Abbott Laboratories) and amino-transferases (Doles), before and after transfusions. Only the last 36 patients were tested for anti HCV (Ortho HCV antibody Elisa Test)R from the beginning. The test were performed at 2, 7, 12 and 24 weeks subsequently in the negative recipients. PTH for type B virus was 3.8% (5/131), and for NANBH 2.7% (3/110). In both groups those recipients who had more transfusions had the greatest incidence of PTH. We conclude that anti HBc and ALT must be done in all blood donors to prevent the occurrence of PTH either B virus or NANBH. We suggest also, to include anti HCV screening in blood donors as a mean to make blood transfusion safer.

Adolescent↗